Results 1 to 10 of about 7,203,866 (304)
Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early
Critical Care Research and Practice, 2021 Background. To compare a titratable insulin infusion order set (vs. nontitratable) and early administration of long-acting insulin in adult patients with diabetic ketoacidosis (DKA). Methods.
Justin Kinney +2 more
doaj +2 more sources
Insulin degludec is a new ultra-long-acting insulin analogue [PDF]
Сахарный диабет, 2014 Achieving optimal glycemic control is an important aspect of preventing and slowing the progression of diabetes-associated complications, and reducing the cost of their treatment.
Ivan Ivanovich Dedov +1 more
doaj +2 more sources
Long-acting insulin allergy in a diabetic child [PDF]
International Journal of Immunopathology and Pharmacology, 2017 Insulin allergy has been uncommon since the introduction of human recombinant insulin preparations; the prevalence is 2.4%. Insulin injection could elicit immediate reactions, which are usually induced by an IgE-mediated mechanism, within the first hour ...
Carla Mastrorilli +5 more
doaj +4 more sources
Effects of intranasal long-acting insulin pretreatment on postoperative delirium and the NLRP3/caspase-1/IL-1β pathway in older patients with esophageal cancer [PDF]
Inflammation and RegenerationBackground Insulin exhibits neuroprotective and anti-inflammatory properties. Preoperative intranasal insulin preconditioning is a potential strategy to prevent postoperative delirium (POD), but prior studies mainly used rapid-acting formulations.
Yong Zhang +5 more
doaj +2 more sources
A comparative study between topical short and long-acting insulin preparations in management of wounds in diabetic patients [PDF]
Journal of Advanced Biomedical and Pharmaceutical Sciences, 2021 Wounds of diabetic patients often require weeks of adequate and appropriate care for full recovery. The use of systemic insulin in diabetic patients was reported to enhance wound healing.
Ahmed Abdel-mawla +3 more
doaj +1 more source
PLoS Medicine, 2021 BackgroundThe rapidly increased spending on insulin is a major public health issue in the United States. Industry marketing might be one of the upstream determinants of physicians' prescription of long-acting insulin-the most commonly used and costly ...
Kosuke Inoue +3 more
doaj +1 more source
Sakarya Tıp Dergisi, 2023 This study was designed to evaluate the box sale trends of insulin preparations and glucagon-like peptide-1 (Glp-1) analogs by their therapeutic categories in Turkey. Also, we aimed to project sale trends of these pharmaceuticals in next years.
Oğuzhan Yıldız +3 more
doaj +1 more source
The journey of insulin over 100 years
Journal of Diabetology, 2022 The year 2021 marks 100 years of insulin discovery. In 1921, Banting and Best identified the pancreas as a key organ mainly responsible for carbohydrate metabolism and pathogenesis of diabetes.
Jayshree Swain +3 more
doaj +1 more source
NEW DRUG IN THE EVOLUTION OF LONG-ACTING INSULINS
Медицинский совет, 2018 Insulin glargine, synthesized using recombinant DNA technology in a concentration of 100 U/ml, was the first once-daily longacting insulin analogue introduced into clinical practice in 2000.
I. V. Kononenko, O. M. Smirnova
doaj +1 more source
Diabetes, Metabolic Syndrome and Obesity, 2022 Wafa A Alsofiani,1 Bandar H Alessa,2 Fahad Alsabaan,3 Abdullah U Althemery,4 Aliah M Ghith,3 Abdullah A Alfaifi4 1Family Medicine and Diabetes Center, Prince Mansour Hospital, Taif, Saudi Arabia; 2Family Medicine Department, National Guard Hospital ...
Alsofiani WA +5 more
doaj